日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Effects of Sodium Glucose Cotransporter 2 Inhibitors by Diabetes Status and Level of Albuminuria: A Meta-Analysis

钠-葡萄糖协同转运蛋白2抑制剂对糖尿病状态和蛋白尿水平的影响:一项荟萃分析

Staplin, Natalie; Roddick, Alistair J; Neuen, Brendon L; Anker, Stefan D; Bhatt, Deepak L; Butler, Javed; Cherney, David Z; Docherty, Kieran F; Fletcher, Robert A; Inzucchi, Silvio E; Jardine, Meg; Mahaffey, Kenneth W; McGuire, Darren K; McMurray, John J V; Neal, Bruce; Packer, Milton; Patel, Siddharth M; Perkovic, Vlado; Sabatine, Marc S; Solomon, Scott; Vaduganathan, Muthiah; Wanner, Christoph; Wheeler, David C; Zannad, Faiez; Haynes, Richard; Heerspink, Hiddo J L; Herrington, William G

Long-Term Effects of Empagliflozin in Patients with Chronic Kidney Disease

恩格列净对慢性肾病患者的长期影响

Herrington, William G; Staplin, Natalie; Agrawal, Nikita; Wanner, Christoph; Green, Jennifer B; Hauske, Sibylle J; Emberson, Jonathan R; Preiss, David; Judge, Parminder; Zhu, Doreen; Dayanandan, Rejive; Arimoto, Ryoki; Mayne, Kaitlin J; Ng, Sarah Y A; Sammons, Emily; Hill, Michael; Stevens, Will; Wallendszus, Karl; Brenner, Susanne; Cheung, Alfred K; Liu, Zhi-Hong; Li, Jing; Hooi, Lai Seong; Liu, Wen; Kadowaki, Takashi; Nangaku, Masaomi; Levin, Adeer; Cherney, David Z I; Maggioni, Aldo P; Pontremoli, Roberto; Deo, Rajat; Goto, Shinya; Rossello, Xavier; Tuttle, Katherine R; Steubl, Dominik; Massey, Dan; Brueckmann, Martina; Landray, Martin J; Baigent, Colin; Haynes, Richard

SGLT2 Inhibitors and Kidney Outcomes by Glomerular Filtration Rate and Albuminuria: A Meta-Analysis

SGLT2抑制剂与肾脏结局(按肾小球滤过率和蛋白尿分级):一项荟萃分析

Neuen, Brendon L; Fletcher, Robert A; Anker, Stefan D; Bhatt, Deepak L; Butler, Javed; Cherney, David Z I; Docherty, Kieran F; Inzucchi, Silvio E; Jardine, Meg J; Mahaffey, Kenneth W; McCausland, Finnian R; McGuire, Darren K; McMurray, John J V; Neal, Bruce; Packer, Milton; Patel, Siddharth M; Perkovic, Vlado; Sabatine, Marc S; Sardell, Rebecca J; Solomon, Scott D; Vaduganathan, Muthiah; Wanner, Christoph; Wheeler, David C; Zannad, Faiez; Haynes, Richard; Staplin, Natalie; Herrington, William G; Heerspink, Hiddo J L

Effects of empagliflozin on quality of life and healthcare use and costs in chronic kidney disease: a health economic analysis of the EMPA-KIDNEY trial

恩格列净对慢性肾脏病患者生活质量、医疗保健利用和成本的影响:EMPA-KIDNEY试验的卫生经济学分析

Zhou, Junwen; Williams, Claire; Staplin, Natalie; Judge, Parminder K; Mayne, Kaitlin J; Agrawal, Nikita; Arimoto, Ryoki; Green, Jennifer B; Cherney, David Z I; Tuttle, Katherine R; Leal, Jose; Clarke, Philip; Emberson, Jonathan R; Preiss, David; Wanner, Christoph; Landray, Martin J; Baigent, Colin; Haynes, Richard; Herrington, William G; Mihaylova, Borislava

Chronic kidney disease and incident cancer risk: an individual participant data meta-analysis

慢性肾脏病与癌症发病风险:一项基于个体参与者数据的荟萃分析

Mok, Yejin; Surapaneni, Aditya; Sang, Yingying; Coresh, Josef; Grams, Morgan E; Matsushita, Kunihiro; Ballew, Shoshana H; Alencar de Pinho, Natalia; Ärnlöv, Johan; Barreto, Sandhi M; Bell, Samira; Brenner, Hermann; Carrero, Juan-Jesus; Chinnadurai, Rajkumar; Ciemins, Elizabeth; Gansevoort, Ron T; Jassal, Simerjot K; Jung, Keum Ji; Kirchner, H Lester; Konta, Tsuneo; Kovesdy, Csaba P; Luo, Li; Pandit, Krutika; Rahman, Mahboob; Robinson-Cohen, Cassianne; Sabanayagam, Charumathi; Schultheiss, Ulla T; Shlipak, Michael; Staplin, Natalie; Tonelli, Marcello; Wang, Angela Yee-Moon; Wen, Chi-Pang; Woodward, Mark; Lees, Jennifer S

Glucose Interference in Urine Biomarkers and Implications for Sodium-Glucose Cotransporter 2 Inhibition

葡萄糖对尿液生物标志物的干扰及其对钠-葡萄糖协同转运蛋白2抑制的影响

Malijan, Greco B; Chapman, Daniel; Moffat, Stewart; Sardell, Rebecca J; Staplin, Natalie; Landray, Martin J; Baigent, Colin; Shlipak, Michael G; Haynes, Richard; Ix, Joachim H; Hill, Michael; Herrington, William G; Judge, Parminder K

Design considerations for future renoprotection trials in the era of multiple therapies for chronic kidney disease

在慢性肾脏病多种疗法并存的时代,未来肾脏保护试验的设计考量

Zhu, Doreen; Judge, Parminder K; Staplin, Natalie; Haynes, Richard; Herrington, William G

The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial

醛固酮合成酶抑制剂维卡司他(BI 690517)改善慢性肾脏病患者心肾结局的潜力:EASi-KIDNEY试验的理论依据

Judge, Parminder K; Tuttle, Katherine R; Staplin, Natalie; Hauske, Sibylle J; Zhu, Doreen; Sardell, Rebecca; Cronin, Lisa; Green, Jennifer B; Agrawal, Nikita; Arimoto, Ryoki; Mayne, Kaitlin J; Sammons, Emily; Brueckmann, Martina; Shah, Shimoli V; Rossing, Peter; Nangaku, Masaomi; Landray, Martin J; Wanner, Christoph; Baigent, Colin; Haynes, Richard; Herrington, William G

An application of the MR-Horse method to reduce selection bias in genome-wide association studies of disease progression

MR-Horse 方法在减少全基因组关联研究中疾病进展选择偏倚的应用

Donovan, Killian; Torres, Jason; Zhu, Doreen; Herrington, William G; Staplin, Natalie

Sodium-Glucose Cotransporter-2 Inhibitors and Major Adverse Cardiovascular Outcomes: A SMART-C Collaborative Meta-Analysis

钠-葡萄糖协同转运蛋白-2抑制剂与主要不良心血管事件:SMART-C合作荟萃分析

Patel, Siddharth M; Kang, Yu Mi; Im, KyungAh; Neuen, Brendon L; Anker, Stefan D; Bhatt, Deepak L; Butler, Javed; Cherney, David Z I; Claggett, Brian L; Fletcher, Robert A; Herrington, William G; Inzucchi, Silvio E; Jardine, Meg J; Mahaffey, Kenneth W; McGuire, Darren K; McMurray, John J V; Neal, Bruce; Packer, Milton; Perkovic, Vlado; Solomon, Scott D; Staplin, Natalie; Vaduganathan, Muthiah; Wanner, Christoph; Wheeler, David C; Zannad, Faiez; Zhao, Yujie; Heerspink, Hiddo J L; Sabatine, Marc S; Wiviott, Stephen D